PROVECTUS BIOPHARMACEUTICALS, INC.
PVCT
DELAYED 1 MONTH

7 insider filings · Latest: Jun 5, 2026

Common Stock Transactions

No transactions found.

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jun 5, 2026Jun 5 6:58 PMEdward PershingDirector, CEO
Option Exercise
9,436—2,857,285(D)

View →

Jun 5, 2026Jun 5 6:58 PMEdward PershingDirector, CEO
Option Exercise
—$2.86—

View →

May 28, 2026May 29 5:22 PMEdward PershingDirector, CEO
Grant/Award
—$2.86—

View →

May 23, 2026May 26 2:56 PMEdward PershingDirector, CEO
Option Exercise
—$2.86—

View →

May 23, 2026May 26 2:56 PMEdward PershingDirector, CEO
Option Exercise
32,089—2,847,849(D)

View →

May 15, 2026May 15 3:53 PMEdward PershingDirector, CEO
Option Exercise
—$2.86—

View →

May 15, 2026May 15 3:53 PMEdward PershingDirector, CEO
Option Exercise
22,651—2,815,760(D)

View →

May 7, 2026May 7 4:23 PMEdward PershingDirector, CEO
Option Exercise
—$2.86—

View →

May 7, 2026May 7 4:23 PMEdward PershingDirector, CEO
Option Exercise
18,876—2,793,109(D)

View →

Mar 12, 2026Mar 17 1:19 AMEdward PershingDirector, CEO
Grant/Award
—$2.86—

View →

Mar 5, 2026Mar 6 4:15 PMEdward PershingDirector, CEO
Grant/Award
—$2.86—

View →